HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
camonagrel
Also Known As:
5-(2-imidazol-1-ylethoxy)-1-indancarboxylic acid; FI 2845; FI-2845
Networked:
2
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Hydrocarbons: 1713
Cyclic Hydrocarbons: 97
Aromatic Hydrocarbons: 291
Polycyclic Aromatic Hydrocarbons: 2020
Indenes: 4
Indans: 7
camonagrel: 2
Polycyclic Compounds: 6
Polycyclic Aromatic Hydrocarbons: 2020
Indenes: 4
Indans: 7
camonagrel: 2
Related Diseases
1.
Atherosclerosis
01/01/1995 - "
Here we report that in patients with peripheral atherosclerosis or in cats with extracorporeal thrombogenesis treatment with camonagrel is associated with activation of fibrinolysis or thrombolysis.
"
2.
Endotoxemia
04/20/1998 - "
Pharmacological analysis of this L-NNA+LPS model by replacing L-NNA with 1-amino-2-hydroxy-guanidine (selective inhibitor of inducible NOS) or by pretreatment with S-nitroso-N-acetyl-penicillamine (NO donor), camonagrel (thromboxane synthase inhibitor), or WEB2170 (platelet-activating factor receptor antagonist) indicated that in the early acute phase of endotoxemia, LPS stimulated the production of cytoprotective NO, cytotoxic thromboxane A2, and platelet-activating factor.
"
Related Drugs and Biologics
1.
Thromboxanes
2.
Thromboxane A2 (A2, Thromboxane)
3.
Platelet Activating Factor
4.
Penicillamine (Cuprimine)
5.
bepafant
6.
platelet activating factor receptor